Venture Initiative

Scientist doing research

Our philosophy

We invest globally in aesthetic healthcare companies who are pursuing innovative, breakthrough science. Our primary goal is to link our expertise with advanced ideas and technologies from emerging companies or academic institutions.

Through the Merz Corporate Venture Capital Initiative, we offer up initial funding in the early stages of development of a company or technology and are committed to further investments in pace with the company’s progress. This could be alone, or in conjunction with other venture capital and investment funds.

In addition to financial backing, we provide extensive experience and a global network that allows our partners to work closely with management teams and fellow investors to create significant value.


Our focus

We are seeking outstanding ideas and promising technologies in aesthetics that are capable of generating a high level of consumer interest, with a specific focus in anti-aging, skin rejuvenation and body-shaping or sculpting technology.

Although our interest is primarily focused on early stage projects and seed investments in aesthetics, our goal is to maximize the value of our entire portfolio, including the development of promising later stage investments and opportunities across all of Merz’s therapeutic focus areas.

Female Scientist

Our value

We pride ourselves on our long-standing commitment to both innovation and continuity. In line with our strategic interests, we are open to proactive and long-term engagement with our partners, and we hope to provide much more than financial backing.

We seek to directly connect our investments to Merz’ global infrastructure by offering access to relevant experts in our scientific research network and providing commercial insights into global to markets.

Our Partners and Investments

Cytrellis Biosystems

Cytrellis is a clinical stage company that has been developing an entirely new category of medical devices for the aesthetics market. Cytrellis’ key proprietary technology removes excess skin without invasive surgery or scarring. This technology will enable physicians to improve sagging skin associated with aging on the face and other areas of the body, thereby addressing one of the aesthetic industry’s largest unmet needs and most valuable opportunities.

Read more

ON Light Sciences

ON Light Sciences is a U.S. medical device company developing technologies to enhance laser-based dermatologic procedures. The company’s flagship product is the FDA 510(k) cleared and CE-marked DeScribe® Transparent PFD Patch, which is placed over tattoos prior to irradiation, allowing physicians to treat tattoos more efficiently by enabling rapid multiple laser passes in a single treatment session.

Read more


Teijin (TSE: 3401) is a technology-driven global group offering advanced solutions in the areas of environmental value; safety, security and disaster mitigation; and demographic change and increased health consciousness. Merz and Teijin Limited have entered into a strategic license and co-development agreement for the commercialization of Xeomin® (incobotulinumtoxinA) for Japan.

Read more

Contact Persons

Meet our team: Each project will be managed by our international interdisciplinary team with broad scientific and commercial expertise. We operate a global network with representatives in our Global Headquarters in Frankfurt, Germany.

Dr. Holger Köhler

Dr. Holger Köhler

Senior Director Corporate Development/M&A

Tel.: +49 69 1503 8882


Iris Manneck

Iris Manneck

Senior Director Corporate Development/M&A

Tel.: +49 69 1503 8419


We are looking forward to learning about your concepts and ideas. If you are seeking funding for your technology, please contact one of our representatives through the contact form below.


Wenn Sie sich initiativ oder auf eine offene Stelle bewerben möchten, benutzen Sie bitte unser Jobportal, welches Sie unter folgendem Link finden:

Bitte beachten Sie, dass wir Ihre Bewerbung nicht berücksichtigen können, wenn Sie diese über einen anderen Kanal senden.

* notwendige Angaben

Bitte beachten Sie, dass, wenn Sie Informationen an Merz übermitteln, alle Materialien, die per elektronischer oder physischer Kommunikation übermittelt werden, als nicht vertraulich betrachtet werden. Senden Sie keine Informationen oder andere Materialien, die Sie als vertraulich oder geschützt betrachten. Obwohl wir nicht die Absicht haben, Details Ihres Vorschlags öffentlich bekannt zu geben, können wir ausgewählte Experten innerhalb oder außerhalb des Merz-Netzwerks zur Bewertung heranziehen.